CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koskinen, P. J.
Right arrow Articles by Eisenman, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koskinen, P. J.
Right arrow Articles by Eisenman, R. N.

Cell Growth & Differentiation, Vol 6, Issue 6 623-629, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions

PJ Koskinen, DE Ayer and RN Eisenman
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA.

Mad is a bHLH/Zip protein that, as a heterodimer with Max, can repress Myc-induced transcriptional transactivation. Expression of Mad is induced upon terminal differentiation of several cell types, where it has been postulated to down-regulate Myc-induced genes that drive cell proliferation. Here we show that Mad also blocks transformation of primary rat embryo fibroblasts by c-Myc and the activated c-Ha-Ras oncoproteins. Mad mutants lacking either the basic region, the leucine zipper, or an intact NH2-terminal protein interaction domain fail to inhibit Myc-Ras cotransformation. These results indicate that the repression of cotransformation requires DNA-binding and is mediated by multiple protein-protein interactions involving both Max and mSin3, a putative mammalian corepressor protein. With increasing amounts of the cotransfected myc gene, the numbers of transformed foci are reduced and the ability of Mad to inhibit focus formation is attenuated. Moreover, cell lines derived from such foci constitutively express both Myc and Mad proteins. Whereas Bcl-2 can significantly increase the numbers of transformed foci by enhancing the survival of myc-ras-transfected cells, it does not counteract the repressive effects of Mad on transformation, suggesting that Mad affects the growth properties rather than the viability of cells. Taken together, our results demonstrate that Mad is capable of antagonizing the biological effects of Myc and thereby suggest that Mad could function as a tumor suppressor gene.


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
K. Jiang, N. Hein, K. Eckert, J. Luscher-Firzlaff, and B. Luscher
Regulation of the MAD1 promoter by G-CSF
Nucleic Acids Res., March 1, 2008; 36(5): 1517 - 1531.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. W. M. Loo, J. Secombe, J. T. Little, L.-S. Carlos, C. Yost, P.-F. Cheng, E. M. Flynn, B. A. Edgar, and R. N. Eisenman
The Transcriptional Repressor dMnt Is a Regulator of Growth in Drosophila melanogaster
Mol. Cell. Biol., August 15, 2005; 25(16): 7078 - 7091.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. Cowley, R. S. Kang, J. V. Frangioni, J. J. Yada, A. M. DeGrand, I. Radhakrishnan, and R. N. Eisenman
Functional Analysis of the Mad1-mSin3A Repressor-Corepressor Interaction Reveals Determinants of Specificity, Affinity, and Transcriptional Response
Mol. Cell. Biol., April 1, 2004; 24(7): 2698 - 2709.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. A. Baudino and J. L. Cleveland
The Max Network Gone Mad
Mol. Cell. Biol., February 1, 2001; 21(3): 691 - 702.
[Full Text]


Home page
Mol. Cell. Biol.Home page
C. Quéva, G. A. McArthur, B. M. Iritani, and R. N. Eisenman
Targeted Deletion of the S-Phase-Specific Myc Antagonist Mad3 Sensitizes Neuronal and Lymphoid Cells to Radiation-Induced Apoptosis
Mol. Cell. Biol., February 1, 2001; 21(3): 703 - 712.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Hasegawa, M. Yasukawa, I. Sakai, and S. Fujita
Transcriptional Down-Regulation of CXC Chemokine Receptor 4 Induced by Impaired Association of Transcription Regulator YY1 with c-Myc in Human Herpesvirus 6-Infected Cells
J. Immunol., January 15, 2001; 166(2): 1125 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. N. Billin, A. L. Eilers, K. L. Coulter, J. S. Logan, and D. E. Ayer
MondoA, a Novel Basic Helix-Loop-Helix-Leucine Zipper Transcriptional Activator That Constitutes a Positive Branch of a Max-Like Network
Mol. Cell. Biol., December 1, 2000; 20(23): 8845 - 8854.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
G. Barrera-Hernandez, C. M. Cultraro, S. Pianetti, and S. Segal
Mad1 Function Is Regulated through Elements within the Carboxy Terminus
Mol. Cell. Biol., June 15, 2000; 20(12): 4253 - 4264.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Gehring, S. Rottmann, A. R. Menkel, J. Mertsching, A. Krippner-Heidenreich, and B. Luscher
Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1. REPRESSION OF Fas-INDUCED CASPASE-8 ACTIVATION
J. Biol. Chem., March 31, 2000; 275(14): 10413 - 10420.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Shen-Li, R. C. O'Hagan, H. Hou Jr., J. W. Horner II, H.-W. Lee, and R. A. DePinho
Essential role for Max in early embryonic growth and development
Genes & Dev., January 1, 2000; 14(1): 17 - 22.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. N. Billin, A. L. Eilers, C. Queva, and D. E. Ayer
Mlx, a Novel Max-like BHLHZip Protein That Interacts with the Max Network of Transcription Factors
J. Biol. Chem., December 17, 1999; 274(51): 36344 - 36350.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
C. Quéva, G. A. McArthur, L. S. Ramos, and R. N. Eisenman
Dwarfism and Dysregulated Proliferation in Mice Overexpressing the MYC Antagonist MAD1
Cell Growth Differ., December 1, 1999; 10(12): 785 - 796.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. L. Eilers, A. N. Billin, J. Liu, and D. E. Ayer
A 13-Amino Acid Amphipathic alpha -Helix Is Required for the Functional Interaction between the Transcriptional Repressor Mad1 and mSin3A
J. Biol. Chem., November 12, 1999; 274(46): 32750 - 32756.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Bahram, S. Wu, F. Oberg, B. Luscher, and L.-G. Larsson
Posttranslational Regulation of Myc Function in Response to Phorbol Ester/Interferon-gamma -Induced Differentiation of v-Myc-Transformed U-937 Monoblasts
Blood, June 1, 1999; 93(11): 3900 - 3912.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. C. Lee and E. B. Ziff
Mxi1 Is a Repressor of the c-myc Promoter and Reverses Activation by USF
J. Biol. Chem., January 8, 1999; 274(2): 595 - 606.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S G Kennedy, A J Wagner, S D Conzen, J Jordan, A Bellacosa, P N Tsichlis, and N Hay
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.
Genes & Dev., March 15, 1997; 11(6): 701 - 713.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Schreiber-Agus, D. Stein, K. Chen, J. S. Goltz, L. Stevens, and R. A. DePinho
Drosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype
PNAS, February 18, 1997; 94(4): 1235 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
P J Hurlin, C Queva, and R N Eisenman
Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites.
Genes & Dev., January 1, 1997; 11(1): 44 - 58.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.